“Alexapath has been funded by the USISTEF!”
Alexapath has received funding in the sum of approximately $200,000 from the United States and India Science and Technology Endowment Fund. The governments of the United States of America (through the Department of State) and India (through the Department of Science & Technology) have established the United States–India Science & Technology Endowment Fund (USISTEF) for the promotion of joint activities that would lead to innovation and entrepreneurship through the application of science and technology. The aim of the Fund is to support and foster joint applied R&D to generate public good through the commercialization of technology developed through sustained partnerships between U.S. and Indian researchers and entrepreneurs. The U.S.-India Science and Technology Endowment Fund activities are implemented and administered through the bi-national Indo-U.S. Science and Technology Forum (IUSSTF).
The award winning project is a collaboration between Alexapath and Aindra technologies entitled “Modular diagnosis of cervical cancer utilizing smartphone diagnostics and artificial intelligence.”
India has more than a third of the global incidences of Cervical Cancers (~140,000) as well as mortalities (~74,000). This number indicates that one woman dies every 7 minutes in India due to a disease that is completely curable, if only detected early.
The proposal aims to build a modular device for the diagnosis of cervical cancer which will be an affordable and portable, ‘point-of-care’ Cervical Cancer Screening tool, to automate the analysis of the PaP smear slides. The slides are stained, scanned, digitized and then analysed using computer algorithms to triage them into normal, suspect and abnormal samples. The images are then sent over a Tele-pathology medium to pathologists for further confirmations and recommendations.